Unique binding behavior of the recently approved angiotensin II receptor blocker azilsartan compared with that of candesartan-Reference-Cited by-同舟云学术

Unique binding behavior of the recently approved angiotensin II receptor blocker azilsartan compared with that of candesartan

Published:2012-10-04 Issue:2 Volume:36 Page:134-139
ISSN:0916-9636
Container-title:Hypertension Research
language:en
Short-container-title:Hypertens Res

Author:

Miura Shin-ichiro,Okabe Atsutoshi,Matsuo Yoshino,Karnik Sadashiva S,Saku Keijiro

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Link

http://www.nature.com/articles/hr2012147.pdf

Reference30 articles.

1. De Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T . International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 2000; 52: 415–472.

2. White WB, Weber MA, Sica D, Bakris GL, Perez A, Cao C, Kupfer S . Effects of the angiotensin receptor blocker azilsartan medoxomil versus olmesartan and valsartan on ambulatory and clinic blood pressure in patients with stages 1 and 2 hypertension. Hypertension 2011; 57: 413–420.

3. Bakris GL, Sica D, Weber M, White WB, Roberts A, Perez A, Cao C, Kupfer S . The comparative effects of azilsartan medoxomil and olmesartan on ambulatory and clinic blood pressure. J Clin Hypertens 2011; 13: 81–88.

4. Sica D, White WB, Weber MA, Bakris GL, Perez A, Cao C, Handley A, Kupfer S . Comparison of the novel angiotensin II receptor blocker azilsartan medoxomil vs. valsartan by ambulatory blood pressure monitoring. J Clin Hypertens 2011; 13: 467–472.

5. Rakugi H, Enya K, Sugiura K, Ikeda Y . Comparison of the efficacy and safety of azilsartan with that of candesartan cilexetil in Japanese patients with grade I-II essential hypertension: a randomized, double-blind clinical study. Hypertens Res 2012; 35: 552–558.

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Azilsartan as a preventive agent against cyclophosphamide-induced testicular injury in male rats;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-08-02

2. Angiotensin Receptor Blockers and the Risk of Suspected Drug-Induced Liver Injury: A Retrospective Cohort Study Using Electronic Health Record-Based Common Data Model in South Korea;Drug Safety;2024-03-21

3. Research Progress in Pharmacological Mechanisms, Structure-Activity Relationship and Synthesis of Sartans;Current Medicinal Chemistry;2023-06

4. Development of a Non-Peptide Angiotensin II Type 1 Receptor Ligand by Structural Modification of Olmesartan as a Biased Agonist;Biomedicines;2023-05-19

5. Inverse Agonist Activity of Angiotensin II Receptor Blocker Is Crucial for Prevention of Aortic Aneurysm Formation in Marfan Syndrome;2022-12-22